Warning
Signs To Watch Out For When Buying A Chemical Business
A recent Wall Street Journal article (April 12, 2001) on
the dispute between CP Kelco (Kelco) and Pharmacia over Kelco’s
$592 million acquisition last year of Monsanto’s biogum division
is must reading for all who are involved in acquisitions and
divestitures in the chemical industry. Whether or not the allegations
contained in Kelco’s lawsuit are true or not, the story provides
a real-life illustration of many of the warning signs a buyer
should look out for when seeking to make an acquisition of a
chemical business.
In the article that follows, we will explore this subject in
more detail.
Kelco is a combination of two related businesses: one acquired
from Monsanto (that is the subject of the dispute) and the other
acquired from Hercules. Kelco itself is owned by a buyout fund
run by Lehman Brothers (the majority shareholder) and Hercules
(the minority shareholder).
Lack of Access
- To Management - One of the claims made by Kelco
is that Monsanto did not allow sufficient access to the
biogum division’s operating executives in the due diligence
period. As a general matter, buyers should always seek access
to key operating personnel in an atmosphere that is conducive
to open and honest discussion. While this type of access
is normally not allowed in the early stages of due diligence,
it usually is appropriate at later stages and certainly
before the buyer commits to the deal. In the early stages
of due diligence, it is common for the seller to make management
presentations for potential buyers. These are often scripted
affairs in structured settings where real access is limited
and in many cases discussions with management are prohibited
or carefully monitored. At a later time, before closing
or committing to a deal, the buyer should insist on having
more free-flowing access to key personnel.
- To Key Customers and/or Suppliers – While not an
issue in the Kelco-Monsanto dispute, lack of access to key
customers or suppliers in some deals could also raise a
red flag to a buyer. When a business is dependant on a very
large customer, or on a key supplier, a buyer may want to
meet with the customer or supplier prior to closing to get
some comfort that the relationship will continue after closing.
For sellers, this can be a very sensitive issue, and so
access is normally granted, if at all, only at very late
stages, just prior to closing.
Rosy Forecasts/Hiding Negative Forecasts - The Kelco-Monsanto
dispute also involves an element that is quite common in many
divestitures – rosy forecasts, or its corollary, the hiding
of negative forecasts. Red flags should go up to any buyer
whenever a seller paints a picture of the future that is significantly
better than the past. We have all seen such “hockey stick”
projections. While such projections may have a sound basis,
they normally do not and it is prudent for a buyer to be skeptical
at first and demand that the seller explain its projections
thoroughly.
Cooking The Books – The Kelco-Monsanto dispute also
involves something that is much less common than the rosy
forecast - i.e. manipulation of the historical earnings of
a business. Kelco maintains that Monsanto’s customers were
induced to make early purchases through price discounts, which
moved income from 2000 to 1999 and had a negative affect on
pricing in 2000.
How To Deal With Red Flags
There are a variety of ways (some of which overlap) for a
buyer to deal these warning signs.
- Don’t Close - Perhaps this is all too obvious,
but in many deals there is a pressure to close regardless
of what problems come up. It may make sense for a buyer
to step back, take stock of where it is, and say, for example
“We can’t close unless we have a full and frank discussion
with operating management”.
- Reduce the price - Another obvious solution in
many cases. It should be noted that in the Kelco-Monsanto
deal, the original price was $685 million and was ultimately
reduced to $592 million, no doubt taking into account many
of the red flags raised in due diligence. Apparently however,
the price was not reduced enough.
- Use Contingent Payments - Making part of the purchase
price contingent on future financial performance is a common
way to solve the “rosy forecast” scenario or where there
otherwise is an uncertainty about the prospects of a business.
- Put It In The Contract – If, for example, a rosy
forecast is being used by the seller to justify a higher
price for the business and a contingent price structure
cannot be agreed to, it is reasonable to ask the seller
to represent that the forecasts have been made in good faith
and are management’s best estimate of future performance.
If the seller chokes on this, the forecasts should be discounted
significantly or perhaps entirely.
- Buy Someone a Drink - This solution is not as facetious
as it sounds. As mentioned before, the divestiture process
is often a scripted affair, with formal presentations and
rigid rules. There have been many deals where an eleventh
hour “confession” or other type of candid conversation with
a key manager takes place before closing in an informal
setting such as at a bar or at dinner. It is in this type
of atmosphere where a buyer can gain valuable information
about a business that does not surface in the formal divestiture
process. If a seller will allow such a meeting, it is highly
recommended. If not, raise the red flag.
|